Low Vitamin D level and impact on severity and recurrence of clostridium difficile infections

Journal of Investigative Medicine

Volumn 63, Issue 1, 2015, Pages 17-21

  Abdelfatah, Mohamed ^a   Nayfe, Rabih ^a   Moftakhar, Bahar ^a   Nijim, Ala ^a   El Zoghbi, Maysaa ^b   Donskey, Curtis J ^c,d   Kandil, Hossam ^e   Watkins, Richard R ^a,f  

^a AKRON GENERAL MEDICAL CENTER   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^e EAST CAROLINA UNIVERSITY   (United States)

^f Northeast Ohio Medical University   (United States)

Author keywords

Clostridium difficile infection; Hypovitaminosis d; Recurrent clostridium difficile; Vitamin D

Indexed keywords

ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; FIDAXOMICIN; METRONIDAZOLE; SERUM ALBUMIN; STEROID; VANCOMYCIN; VITAMIN D;

ABDOMINAL TENDERNESS; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; DIABETES MELLITUS; DIARRHEA; DISEASE SEVERITY; FEMALE; HUMAN; ILEUS; MAJOR CLINICAL STUDY; MALE; MEGACOLON; POLYMERASE CHAIN REACTION; RECURRENT INFECTION; RETROSPECTIVE STUDY; SEPSIS; VITAMIN BLOOD LEVEL; BLOOD; CLOSTRIDIUM INFECTION; DEMOGRAPHY; MICROBIOLOGY; MORTALITY; PEPTOCLOSTRIDIUM DIFFICILE; PHYSIOLOGY; RECURRENT DISEASE;

AGED; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DEMOGRAPHY; FEMALE; HUMANS; MALE; RECURRENCE; VITAMIN D;

EID: 84940109570     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.1097/JIM.0000000000000117     Document Type: Article

References (21)

1. Bartlett JG. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med. 2006;145:758-764.
2. Youssef D, Bailey B, El Abbassi A, et al. Healthcare costs of Staphylococcus aureus and Clostridium difficile infections in veterans: role of vitamin D deficiency. Epidemiol Infect. 2010;138:1322-1327.
3. O'Connor KA, Kingston M, O'Donovan M, et al. Antibiotic prescribing policy and Clostridium difficile diarrhoea. QJM. 2004;97:423-429.
4. Buffet-Bataillon S, Tattevin P, Senechal H, et al. Clostridium difficile O27 colitis: hospital-onset but community-acquired. Eur J Clin Microbiol Infect Dis. 2012;31:2263-2267.
5. Van Der Wilden GM, Fagenholz PJ, Velmahos GC, et al. Vitamin D status and severity of Clostridium difficile infections: a prospective cohort study in hospitalized adults. JPEN J Parenter Enteral Nutr. 2014 Jan 9. [Epub ahead of print].
6. Hewison M. Vitamin D and the intracrinology of innate immunity. Mol Cell Endocrinol. 2010;321:103-111.
7. Youssef DA, Ranasinghe T, Grant WB, et al. Vitamin D's potential to reduce the risk of hospital-acquired infections. Dermatoendocrinol. 2012;4:167-175.
8. Cannell JJ, Vieth R, Umhau JC, et al. Epidemic influenza and vitamin D. Epidemiol Infect. 2006;134:1129-1140.
9. Arnedo-Pena A, Juan-Cerdan JV, Romeu-Garcia A, et al. Latent tuberculosis infection, tuberculin skin test and vitamin D status in contacts of tuberculosis patients: a cross-sectional and case-control study. BMC Infect Dis. 2011;11:349.
10. Haug C, Muller F, Aukrust P, et al. Subnormal serum concentration of 1, 25-vitamin D in human immunodeficiency virus infection: correlation with degree of immune deficiency and survival. J Infect Dis. 1994;169:889-893.
11. Quraishi SA, Litonjua AA, Moromizato T, et al. Association between prehospital vitamin D status and hospital-acquired bloodstream infections. Am J Clin Nutr. 2013;98:952-959.
12. Amrein K, Zajic P, Schnedl C, et al. Vitamin D status and its association with season, hospital and sepsis mortality in critical illness. Crit Care. 2014;18:R47.
13. Moromizato T, Litonjua AA, Braun AB, et al. Association of low serum 25-hydroxyvitamin D levels and sepsis in the critically ill. Crit Care Med. 2014;42:97-107.
14. Quraishi SA, Bittner EA, Christopher KB, et al. Vitamin D status and community-acquired pneumonia: results from the third National Health and Nutrition Examination Survey. PLoS One. 2013;8:e81120.
15. Grant WB. Critique of the U-shaped serum 25-hydroxyvitamin D level-disease response relation. Dermatoendocrinol. 2009;1:289-293.
16. Wang WJ, Gray S, Sison C, et al. Low vitamin D level is an independent predictor of poor outcomes in Clostridium difficileYassociated diarrhea. Therap Adv Gastroenterol. 2014;7:14-19.
17. Quraishi SA, Litonjua AA, Moromizato T, et al. Association between prehospital vitamin D status and hospital-acquired Clostridium difficile infections. JPEN J Parenter Enteral Nutr. 2014 Feb. 3. [Epub ahead of print].
18. Wilcox MH, Fawley WN, Settle CD, et al. Recurrence of symptoms in Clostridium difficile infectionVrelapse or reinfection?. J Hosp Infect. 1998;38:93-100.
19. Fekety R, McFarland LV, Surawicz CM, et al. Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial. Clin Infect Dis. 1997;24:324-333.
20. Kelly CP, LaMont JT. Clostridium difficileVmore difficult than ever. N Engl J Med. 2008;359:1932-1940.
21. Quraishi SA, Camargo CA Jr. Vitamin D in acute stress and critical illness. Curr Opin Clin Nutr Metab Care. 2012;15:625-634.